LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 113 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $29,423 | -48.6% | 26,994 | +8.0% | 0.00% | – |
Q2 2023 | $57,220 | +13.6% | 24,987 | +20.5% | 0.00% | – |
Q1 2023 | $50,379 | +27.2% | 20,732 | 0.0% | 0.00% | – |
Q4 2022 | $39,598 | -20.8% | 20,732 | +0.2% | 0.00% | – |
Q3 2022 | $50,000 | +28.2% | 20,700 | 0.0% | 0.00% | – |
Q2 2022 | $39,000 | +69.6% | 20,700 | +88.2% | 0.00% | – |
Q1 2022 | $23,000 | -90.1% | 11,000 | -70.2% | 0.00% | – |
Q2 2019 | $232,000 | +11.5% | 36,931 | -1.2% | 0.00% | – |
Q1 2019 | $208,000 | +3.5% | 37,397 | +23.6% | 0.00% | -100.0% |
Q4 2018 | $201,000 | -44.0% | 30,261 | -10.0% | 0.00% | 0.0% |
Q3 2018 | $359,000 | -10.0% | 33,620 | +1.1% | 0.00% | 0.0% |
Q2 2018 | $399,000 | +59.6% | 33,245 | +14.0% | 0.00% | 0.0% |
Q1 2018 | $250,000 | +16.3% | 29,172 | +34.1% | 0.00% | 0.0% |
Q4 2017 | $215,000 | -38.0% | 21,746 | -22.9% | 0.00% | 0.0% |
Q3 2017 | $347,000 | -13.2% | 28,220 | +16.1% | 0.00% | -50.0% |
Q2 2017 | $400,000 | -8.0% | 24,314 | -20.6% | 0.00% | -33.3% |
Q1 2017 | $435,000 | – | 30,640 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ulys, L.L.C. | 4,321,214 | $14,779,000 | 100.00% |
Artal Group S.A. | 71,178,364 | $243,430,000 | 5.23% |
BVF INC/IL | 10,963,000 | $37,493,000 | 1.48% |
Integral Health Asset Management, LLC | 300,000 | $1,026,000 | 0.30% |
NEA Management Company, LLC | 2,382,286 | $8,147,000 | 0.22% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $122,000 | 0.13% |
PINNACLE ASSOCIATES LTD | 1,852,382 | $6,335,000 | 0.13% |
XTX MARKETS LLC | 13,242 | $45,000 | 0.09% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 828,192 | $2,832,000 | 0.06% |
WINTON GROUP Ltd | 192,890 | $660,000 | 0.05% |